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progressive loss of the articular cartilage matrix due to an imbalance
between matrix synthesis and degradation. Loss in the chondrocytes ability
to respond to growth factor stimulation may be a key factor contributing
to the development of OA and RA. We recently found that enforced expres-
sion of SOCS3 caused IGF-1 resistance in chondrocytes, thereby preventing
upregulation of matrix proteoglycan synthesis. This study is designed to
determine the expression of SOCS3 in human pathological chondrocytes
and unravel the biological/functional consequences.
Methods: Chondrocytes were isolated from cartilage of patients under-
going surgical joint replacement. The mRNA and protein levels of SOCS1
and SOCS3 were measured by qPCR and Western blotting. Levels of
SOCS3 were compared to a human immortalized chondrocyte cell-line
(G6), mesenchymal-stem cells differentiated chondrocytes, and primary
chondrocytes isolated from healthy bovine cartilage or from a SLE patient.
The regulation of SOCS1 and 3 expression was studied in OA chondrocytes
by incubation with different cytokines and TLR agonists. To determine the
functional consequences the cytokine and TLR ligand-induced nitric-oxide
production and IGF-1-stimulated proteoglycan (PG) synthesis was studied.
Results: The SOCS3 mRNA expression in articular chondrocytes and car-
tilage was markedly upregulated (32-fold) in 21/24 OA, 5/5 RA patients,
3/3 trauma patients tested, as compared to the G6 cell-line, stem cell-
differentiated chondrocytes, and chondrocytes derived from a SLE-patient.
Exposure of the mesenchymal stem cell-derived chondrocytes with con-
ditioned media of OA synovial explants upregulated SOCS3 to the same
extent as seen in the OA chondrocytes. Expression of SOCS3 could not
be upregulated signiﬁcantly in OA chondrocytes by the different cytokines
(IL-1β, IL-17, IL-18) and TLR ligands (LPS, Pam2Cys, Poly(I:C), FK156, MDP)
used. In contrast, SOCS1 expression was markedly lower (20-fold) in
comparison to SOCS3 in OA chondrocytes and could be upregulated to the
level of SOCS3 using IL-1β, IFNγ, IL-17, Pam2Cys, Poly(I:C), and especially
with the combination of IFNγ and Poly(I:C). SOCS3 expression in OA
chondrocytes was conﬁrmed at the protein level. This means that at least
in SOCS3 and SOCS1 genes are independently regulated and that SOCS3 has
reached the maximal expression level. In the OA chondrocytes, the TLR4
ligand LPS was unable to induce NO production and IGF-1 failed to stim-
ulate PG synthesis. Forced expression of SOCS3 in bovine cartilage-derived
chondrocytes blocked the LPS (NO) and IGF-1 (PG-synthesis) response in
these cells.
Conclusions: We found increased SOCS3 but not SOSC1 expression in
human pathological chondrocytes. SOCS3 could block TLR4 and IGF-1
activation in chondrocytes. This suggests that SOCS3 modiﬁes normal chon-
drocyte function and this could play a major role in cartilage pathology
during arthritis.
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Purpose: Patient heterogeneity is probably one of the reasons for failure
of osteoarthritis (OA) clinical trials. OA research has focused on cartilage
destruction, while recent evidence shows other joint tissues, including
adipose and synovial tissue, also play important roles in OA pathogenesis.
Current literature indicates overweight is not only mechanically associated
with OA, but also biochemically. Synovium modiﬁcation leading to cartilage
destruction is hypothesized to be a possible mechanism in OA development.
We aim to investigate the inﬂuence of OA-derived synovium, in relation to
body mass index (BMI), on cartilage metabolism.
Methods: Synovium of 16 OA and 8 healthy human donors with different
BMI was cultured alone or together with bovine cartilage explants with
or without stimulation by IL-1α. After 7 days, proteoglycan (PG) release,
matrix metalloproteinase (MMP) activity and cytokines were measured.
Cytokine proﬁles were subjected to multivariate analysis.
Results: Co-cultures of healthy or OA synovium with cartilage showed
no differences in PG release without IL-1α stimulation. However, IL1-α
stimulated co-cultures lead to a higher PG release from cartilage for OA
compared to healthy synovium (54% vs 45% p=0.03). OA donors having
BMI>30 induced a higher PG release then donors having BMI<30 (57% vs
48% p=0.006). With respect to MMP activity, no differences between OA
and healthy synovium were observed. Multivariate analysis showed that
synovium alone or in co-culture with cartilage can be distinguished based
on their cytokine proﬁle.
Conclusions: PG-release, a major process in OA development, is more
prominent in co-cultures with OA-derived synovium compared to healthy
synovium. BMI might prove to be a useful tool to stratify OA patient as
synovium explants of high BMI OA donors lead to more cartilage degrada-
tion then synovium explants of low BMI OA donors. Interaction between
synovium and cartilage leads to modiﬁcation of cytokine proﬁles.
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Purpose: Cartilage and synovial tissue are both affected in osteoarthritis
(OA) and are known to interact. However, a long-term co-culture model
with synovial tissue and cartilage explants has not been described before.
Such a co-culture will provide a suitable model to study these interactions
and mimic the OA joint more closely as well as to screen new therapies for
cartilage degeneration in OA. Therefore, the aim of the study is to develop
an in vitro model that includes both OA synovial tissue and cartilage, which
can be used for testing new therapies for OA.
Methods: Osteoarthritic cartilage and synovial tissue were cultured to-
gether or alone for 21 days. To screen the effect of a therapeutic compound
in the co-culture model, Triamcinolone 0.1mM was added to the culture
media. To assess viability of the synovial tissue immunohistochemistry, a
live/dead assay, and the release of lactate dehydrogenase (LDH) were used.
Dimethylmethylene-blue assay was used to determine glycosaminoglycan
(GAG) release and content of cartilage. Multiplex ELISA was used to deter-
mine the concentrations of secreted IL1, IL1-RA, IL4, IL6, IL7, IL8, IL10, IL13,
TNF-alfa, oncostatin M, IFN-gamma, osteoprotegerin in the culture media.
Results: Throughout the entire culture synovial tissue showed viable cells
by a LDH assay, a live/dead assay and immunohistochemistry demonstrated
the presence of macrophages and T-cells. Several cytokines, which were
previously demonstrated in synovial ﬂuid of osteoarthritic patients, were
secreted by synovial tissue during the entire culture period, indicating that
the synovial tissue is still capable of producing cytokines during culture.
Co-culture of cartilage and synovial tissue enhanced GAG release and
reduced GAG content after 21 days of culture compared to cartilage
Figure 1. GAG content from 6 donors (mean ± SD in μg GAG/gram cartilage; *P<0.05).
Figure 2. GAG content co-culture cultured with or without Triamcinolone (mean ± SD in
μg GAG/gram cartilage).
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Figure 3. Cytokine proﬁles from co-culture cultured with or without Triamcinolone cytokine proﬁle day 11).
alone (Fig. 1). Addition of Triamcinolone to the co-culture inhibited these
catabolic effects of synovial tissue on cartilage on GAG content (Fig. 2).
Cytokine proﬁles from the culture medium showed that both tissues
secreted cytokines. In cartilage cultured alone some cytokine that are
normally present in synovial ﬂuid of OA patients were not detected in the
medium. In the co-culture of cartilage and synovial tissue most cytokines
were present, indicating that for mimicking the osteoarthritic environment
both tissues are required. Addition of Triamcinolone decreased the amount
of cytokines released by the cartilage as well as the cytokines from the
synovial tissue (Fig. 3).
Conclusions: From the present data, we conclude that it is possible to
culture synovial tissue explants for at least 21 days. A co-culture with
synovial tissue explants enhances GAG release by the cartilage explants,
indicating the catabolic environment that is present in OA is mimicked
more closely in co-culture than in single explant culture. We demonstrate
the possibility to modulate this breakdown on both cartilage as synovial
tissue level by adding Triamcinolone. This study indicates the applicability
of this co-culture model to study the interaction between cartilage and
synovial tissue. Furthermore this model can be used for screening new
modulators of cartilage degeneration in OA.
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Purpose: Osteoarthritis (OA) features an imbalance of anabolic and
catabolic processes, ultimately resulting in loss of function and destruction
of cartilage. The major proteoglycan of articular cartilage, aggrecan, pro-
vides impact absorption and load bearing properties to the tissue. In OA,
ADAMTS-4 and ADAMTS-5 are key enzymes responsible for the degradation
of aggrecan. We have previously demonstrated that oral treatment with
an Aggrecanase Selective Inhibitor (ASI) in a rat model of joint injury/OA
is chondroprotective. Cytokine-induced bovine articular cartilage explants
are a common in vitro model of cartilage degradation, whereas in vitro
rat cartilage explant assays have not been extensively described. This
study investigated whether rat articular cartilage can be induced to release
aggrecan in response to catabolic stimuli, and whether the induction can
be attenuated by treatment with ASI.
Methods: Individual femoral head cartilage explants from approximately
3-week old male Lewis rats were cultured in 96-well plates. Treatments of
six wells per group consisted of a variety of cytokines or all-trans retinoic
acid (RA), +/- ASI (dose ranging between ∼80-5200nM) were cultured for
3 days with daily media exchange. Residual explants were digested with
1mg/ml proteinase K and aggrecan sGAG release was determined by assay-
ing culture media and cartilage extracts using DMMB. sGAG release was
normalized per cartilage weight and as a percentage of total sGAG per well.
Aggrecan cleavage by aggrecanases was measured by 374ARGN-aggrecan
ELISA as previously described. Relative cellular activity was determined
using a lactate colorimetric assay.
Results: Initial studies compared a number of induction conditions to iden-
tify a treatment that resulted in the greatest release of sGAG and 374ARGN
neoepitope in rat hip cartilage explant culture. Human TNF-α (100ng/ml),
IL-1α +/- OSM (both 10ng/ml) as well as mouse IL-1α and β (10ng/ml) failed
to signiﬁcantly induce sGAG release. Treatment with rat IL-1α and β and
human IL-1β (all 10ng/ml) resulted in an induction window of sGAG release
of 2× over background. The greatest induction by day 3 was generated
with 1 or 10μM RA resulting in ∼3× above background sGAG and 10-30×
374ARGN neoepitope. Lactate levels in conditioned media indicated that all
treatments were well tolerated as cellular activity was within 85% of the
media group. Treatment of explants with 1μM RA in the presence of ASI
resulted in dose-dependent inhibition of both sGAG and ARGN-aggrecan
release, demonstrating that sGAG release is aggrecanase-mediated, as in
bovine explant culture systems.
Conclusions: Similar to previously established bovine models, rat articular
cartilage can be induced to catabolize aggrecan in an aggrecanase-
dependent process, which can be prevented by treatment with an ag-
grecanase inhibitor. Since relative differences in ADAMTS-4 or ADAMTS-5
activities may exist between species, this assay will be useful as a tool
for pre-screening and selection of compounds for evaluation in rat in vivo
models.
474
CAPSULAR CHANGES IN A RAT IMMOBILIZED KNEE MODEL
Y. Hagiwara1, A. Ando2, Y. Onoda3, E. Chimoto4, K. Hatori5, H. Suda6,
E. Itoi3
1Takeda Gen. Hosp., Aizuwakamatsu, Japan; 2Funabashi Orthopaedic Clinic,
Sports Med. Ctr., Funabashi, Japan; 3Tohoku Univ. Sch. of Med., Dept. of
Orthopaedic Surgery, Sendai, Japan; 4Tohoku Univ. Sch. of Med., Deparment of
Orthopaedic Surgery, Sendai, Japan; 5Tohoku Univ. Sch. of Dentistry, Div. of
Advanced Prosthetic Dentistry, Sendai, Japan; 6Tohoku Univ. Sch. of Med.,
Dept. of Orthpaedic Surgery, Sendai, Japan
Purpose: Joint immobilization is a useful and commonly performed
treatment modality in orthopedics, however, it also causes unfavorable
outcomes such as joint contracture, periarticular osteoporosis, and cartilage
degeneration. Once joint contracture is established, it is extremely diﬃcult
to regain a full range of motion (ROM) with vigorous and extensive rehabil-
itation, or even with surgical treatment. Joint contracture is classiﬁed into
two types according to its etiology: arthrogenic (bone, cartilage, synovial
membrane, capsule, and ligaments) and myogenic (muscle, tendon, and
fascia). Some investigators insisted on an importance of the myogenic
components, whereas others did on the arthrogenic ones. Among the
arthrogenic components, capsular stiffness might contribute more to joint
contracture than the other ones. In our previous study, ROM after total
extra-articular myotomies was increased after the capsular release, which
indicated the capsule was one of the main causes of joint contracture.
Determination of the expression levels of structural collagens (collagen
types I and III), and ﬁbrogenetic factors, such as connective tissue growth
factor (CTGF) and transforming growth factor-β1 (TGF-β1) are a key to un-
derstand the elastic changes of the capsule. The purpose of this study was
to elucidate expression patterns of the capsule after joint immobilization
in a rat knee ﬂexion contracture model by multidirectional approach.
Methods: Unilateral knee joints of adult male Sprague-Dawley rats (body
weight, 380-400 g) were rigidly immobilized at 150° of ﬂexion with a
plate and screws for various periods (3 days, 1, 2, 4, 8, and 16 weeks).
Sham-operated animals had holes drilled in the femur and tibia with
screws inserted without a plate. The immobilized animals and the sham-
operated animals made up the immobilized group and the control group,
respectively. Five-μm sections at the medial midcondylar region in sagittal
plane were obtained for in situ hybridization (ISH) and immunohistochem-
istry (IHC). The capsules, without tendons, ligaments, and muscles, were
obtained with a surgical knife for quantitative PCR (qPCR) and Western
blotting (WB). Collagen types I and III were evaluated by ISH, qPCR, IHC,and
WB. CTGF and TGF-β1 were investigated by ISH and IHC.
Results: Expressions of collagen types I and III were decreased after immo-
